The assay enables each ABI 3730xl sequencer to manage over 2,000 samples a day. Credit: Mufid Majnun / Unsplash.

Eurofins Technologies has launched a fast and cost-effective high throughput kit, GSD NovaPrime SARS-CoV-2 Mplex FLA (Sanger), for Covid-19 testing.

The device works on the fragment length analysis principle on Sanger sequencing instruments such as ABI 3730xl.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The assay enables each ABI 3730xl sequencer to manage over 2,000 samples a day.

With the pandemic pushing qRT-PCR testing capacities to its limits, the kit can substantially improve high throughput capacities of highly sensitive tests.

Designed to detect two highly specific N1 and N2 gene fragments of the SARS-CoV-2 viral genome with high sensitivity, GSD NovaPrime SARS-CoV-2 Mplex FLA (Sanger) assay’s limit of detection equals best available qRT-PCR assays.

The kit’s limit of detection is five copies per reaction.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, sensitivity and time to results of the new kit are similar to qRT-PCR testing.

Its multiplex reactions include a human housekeeping gene that acts as an intrinsic control in RNA extracted from nasopharyngeal swabs to enable successful sampling, extraction, amplification, and detection process.

Currently, research-use-only (RUO) version of the GSD NovaPrime SARS-CoV-2 Mplex FLA (Sanger) kit has been launched in Europe to help laboratories to start their internal validation and implementation activities.

The CE-IVD marked kit will be completed and made available soon.

Eurofins also plans to submit an application with the Food and Drug Administration (FDA) for emergency use authorisation (EUA) of the kit.

Development of the kit was led by Eurofins Genomics. The kit will be deployed with Eurofins Clinical testing laboratories in Europe to provide high sensitivity tests to healthcare authorities in the continent.